同源康医药-B(02410)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02410 同源康医药-B

已收盘 01-09 16:08:35

14.300

+0.620

+4.53%

最高14.440	最低13.700	成交量594.70万
今开13.700	昨收13.680	日振幅5.41%
总市值54.35亿	流通市值53.69亿	总股本3.80亿
成交额8,403万	换手率1.58%	流通股本3.75亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"同源康医药-B","latestPrice":14.3,"timestamp":1767946115005,"preClose":13.68,"halted":0,"volume":5947046,"delay":0,"floatShares":375457818,"shares":380065818,"eps":-1.2798383895805236,"marketStatus":"已收盘","change":0.62,"latestTime":"01-09 16:08:35","open":13.7,"high":14.44,"low":13.7,"amount":84032055,"amplitude":0.054094,"askPrice":14.3,"askSize":6000,"bidPrice":14.29,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":-0.8619135177152925,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768181400000},"marketStatusCode":5,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":13.68,"openAndCloseTimeList":[[1767922200000,1767931200000],[1767934800000,1767945600000]],"volumeRatio":1.203472,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02410","defaultTab":"news","newsList":[{"id":"2602344302","title":"港股异动 | 同源康医药-B(02410)午后涨超4% 甲磺酸艾多替尼片(TY-9591片)拟纳入优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2602344302","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602344302?lang=zh_cn&edition=full","pubTime":"2026-01-09 14:01","pubTimestamp":1767938461,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B(02410)午后涨超4%，截至发稿，涨3.87%，报14.21港元，成交额5940.29万港元。消息面上，同源康医药发布公告，本公司在研1类新药甲磺酸艾多替尼片(TY-9591片)被国家药品监督管理局(NMPA)药品审评中心拟纳入优先审评品种名单，拟定适应症为：具有表皮生长因子受体(EGFR)外显子19缺失 (19DEL)或外显子21(L858R)置换突变，并伴有中枢神经系统(CNS)转移的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者的一线治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390815.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","09939","BK1574","BK1161","02410","TY","159938"],"gpt_icon":0},{"id":"2601325361","title":"每日卖空追踪 | 同源康医药-B 01月08日卖空量成交2.1万股，卖空比例为0.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601325361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601325361?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:30","pubTimestamp":1767861031,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间01月08日，跌2.08%，卖空量成交2.1万股，较上一交易日减少45.45%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164737a7023d65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164737a7023d65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1515","BK1574","02410","BK1161"],"gpt_icon":0},{"id":"2601388023","title":"同源康医药-B：股价异常波动 无应披露重大信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2601388023","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601388023?lang=zh_cn&edition=full","pubTime":"2026-01-07 23:14","pubTimestamp":1767798840,"startTime":"0","endTime":"0","summary":"格隆汇1月7日丨同源康医药-B(02410.HK)公告，董事会已注意到公司股份价格及成交量近期出现不寻常波动。经作出合理查询后，董事会确认，除上文所披露者外，截至本公告日期，其并不知悉导致有关波动的任何原因，或为避免公司证券出现虚假市场而须予披露的任何资料，或根据香港法例第571章证券及期货条例第XIVA部须予披露的任何内幕消息。截至本公告日期，董事会确认集团的业务经营正常稳定，其核心业务进展顺利，并无任何引起董事会和公司管理层关注的须予披露的重大事项。本文来自和讯财经，更多精彩资讯请下载“和讯财经”APP追加内容本文作者可以追加内容哦 !","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107231633a6ff4a57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107231633a6ff4a57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1161","BK1574","09939","BK1515"],"gpt_icon":0},{"id":"2601804835","title":"同源康医药-B(02410)：甲磺酸艾多替尼片(TY-9591片)拟纳入优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2601804835","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601804835?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:49","pubTimestamp":1767797362,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B 发布公告，本公司在研1类新药甲磺酸艾多替尼片被国家药品监督管理局药品审评中心拟纳入优先审评品种名单，拟定适应症为：具有表皮生长因子受体外显子19缺失 或外显子21置换突变，并伴有中枢神经系统转移的局部晚期或转移性非小细胞肺癌成人患者的一线治疗。董事会亦已注意到本公司股份价格及成交量近期出现不寻常波动。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390102.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","TY","159938","BK1574","02410","BK1161","BK1515"],"gpt_icon":0},{"id":"1111028643","title":"同源康医药-B：Asandeutertinib (Ty-9591) 获纳入中国国家药监局优先审评产品名单","url":"https://stock-news.laohu8.com/highlight/detail?id=1111028643","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111028643?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:45","pubTimestamp":1767797115,"startTime":"0","endTime":"0","summary":"同源康医药股份有限公司（简称“同源康医药-B”）宣布，其研发的创新药物Asandeutertinib（研发代号：Ty-9591）已被中国国家药品监督管理局（NMPA）正式纳入优先审评品种名单。\n这一重要进展意味着，该药物在后续的上市审评审批过程中将获得加速通道，有望更早惠及中国患者。Asandeutertinib是一种针对特定靶点的小分子抑制剂，其研发进展备受市场关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"gpt_icon":0},{"id":"2601938804","title":"每日卖空追踪 | 同源康医药-B 01月07日卖空量成交1.75万股，卖空比例为0.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601938804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601938804?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:30","pubTimestamp":1767774630,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间01月07日，涨8.13%，卖空量成交1.75万股，较上一交易日增加6.06%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163430a6fdde8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163430a6fdde8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02410","BK1515","09939","BK1161"],"gpt_icon":0},{"id":"2601638802","title":"同源康医药-B01月07日主力净流入750.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2601638802","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601638802?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:15","pubTimestamp":1767773733,"startTime":"0","endTime":"0","summary":"01月07日, 同源康医药-B股价涨8.13%，报收13.97元，成交金额2.2亿元，换手率4.12%，振幅10.76%，量比6.34。同源康医药-B今日主力资金净流入750.0万元，上一交易日主力净流出122.3万元。该股近5个交易日上涨5.84%，主力资金累计净流入1029.0万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入3517.4万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107161759a6fdc927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107161759a6fdc927&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09939","BK1574","BK1515","02410"],"gpt_icon":0},{"id":"2601942847","title":"港股异动 | 同源康医药-B(02410)最高涨超10% TY-9591片拟纳入优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2601942847","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601942847?lang=zh_cn&edition=full","pubTime":"2026-01-07 09:39","pubTimestamp":1767749996,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B(02410)涨超10%，截至发稿，涨7.97%，报13.95港元，成交额3266.34万港元。消息面上，1 月 6 日，CDE 官网显示，同源康医药申报的甲磺酸艾多替尼片（TY-9591 片）拟纳入优先审评，用于具有表皮生长因子受体（EGFR）外显子 19 缺失（19DEL）或外显子 21（L858R）置换突变，并伴有中枢神经系统（CNS）转移的局部晚期或转移性非小细胞肺癌（NSCLC）成人患者的一线治疗。值得一提的是，在去年9月份的世界肺癌大会上，同源康医药发布的艾多替尼片针对非小细胞肺癌脑转移关键Ⅱ期临床试验引起同行高度关注。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389637.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02410","159938","09939","BK1161","BK1515","TY"],"gpt_icon":0},{"id":"2601882780","title":"每日卖空追踪 | 同源康医药-B 01月05日卖空量成交1.4万股，卖空比例为0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601882780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601882780?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:30","pubTimestamp":1767601829,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间01月05日，跌0.08%，卖空量成交1.4万股，较上一交易日增加86.67%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163547a49e29b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163547a49e29b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1515","BK1574","02410","BK1161"],"gpt_icon":0},{"id":"2600707100","title":"智通港股沽空统计|1月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=2600707100","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600707100?lang=zh_cn&edition=full","pubTime":"2026-01-01 08:20","pubTimestamp":1767226822,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，长和、中电控股、香港中华煤气上一交易日沽空比率位于前三位，分别为0.00%、0.00%、0.00%。能源及能量环球、沪上阿姨、中船防务的偏离值位居前三，分别为-0.41%、-0.41%、-0.66%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387988.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","00317","LU1497733631.SGD","IE00BG0RBZ43.SGD","BK1521","02410","00008","BK1240","02589","LU1571399168.USD","LU0516422440.USD","06683","LU1508157978.USD","BK1237","00003","HSNGY","BK1230","LU0417516738.SGD","01142","00010","BK1231","00005","LU1497734951.SGD","00001","BK1610","LU1634259557.SGD","00011","HSBA.UK","HSBC","02562","BK1111","01635","03143","00006","BK1099","HSHD.SI","SG9999003461.SGD","00002","02451","01709","80011","00012","LU0072462343.USD","LU0540923850.HKD","LU0831103253.SGD","BK1189","00004","03145","06681","SG9999001093.SGD"],"gpt_icon":0},{"id":"2600770809","title":"每日卖空追踪 | 同源康医药-B 12月31日卖空量成交5500股，卖空比例为0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600770809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600770809?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:30","pubTimestamp":1767169830,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间12月31日，跌0.61%，卖空量成交5500股，较上一交易日减少84.72%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231163428a48dc78e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231163428a48dc78e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09939","BK1574","BK1515","02410"],"gpt_icon":0},{"id":"2595438757","title":"港股异动 | 同源康医药-B(02410)现涨超6% TYK-01054胶囊启动I/II期临床 适应症为晚期实体瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2595438757","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595438757?lang=zh_cn&edition=full","pubTime":"2025-12-30 10:13","pubTimestamp":1767060800,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B现涨超6%，截至发稿，涨4.6%，报13.41港元，成交额2088.14万港元。消息面上，药物临床试验登记与信息公示平台数据显示，浙江同源康医药股份有限公司的一项评估TEAD抑制剂TYK-01054胶囊在局部进展或转移性晚期实体瘤患者中的安全性、耐受性、药代动力学和抗肿瘤活性的I/II期、开放标签、多中心研究已启动。临床试验登记号为CTR20255003，首次公示信息日期为2025年12月26日。公开资料显示，TYK-01054胶囊为化学药物，适应症为晚期实体瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","02410","09939","BK1574","BK1515","BK1161"],"gpt_icon":0},{"id":"2595673485","title":"每日卖空追踪 | 同源康医药-B 12月29日卖空量成交2.9万股，卖空比例为1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595673485","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595673485?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:30","pubTimestamp":1766997029,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间12月29日，股价较前一交易日持平，卖空量成交2.9万股，较上一交易日增加107.14%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163421a6dc49ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163421a6dc49ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1515","09939","02410"],"gpt_icon":0},{"id":"2594823211","title":"同源康医药TYK-01054胶囊启动I/II期临床 适应症为晚期实体瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2594823211","media":"新浪财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594823211?lang=zh_cn&edition=full","pubTime":"2025-12-26 12:31","pubTimestamp":1766723460,"startTime":"0","endTime":"0","summary":"药物临床试验登记与信息公示平台数据显示，浙江同源康医药股份有限公司的一项评估TEAD抑制剂TYK-01054胶囊在局部进展或转移性晚期实体瘤患者中的安全性、耐受性、药代动力学和抗肿瘤活性的I/II期、开放标签、多中心研究已启动。TYK-01054胶囊为化学药物，适应症为晚期实体瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226123258a47a1aa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226123258a47a1aa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1574","02410","BK1161","BK1515"],"gpt_icon":0},{"id":"2593499153","title":"每日卖空追踪 | 同源康医药-B 12月23日卖空量成交2500股，卖空比例为0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593499153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593499153?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:30","pubTimestamp":1766478630,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间12月23日，跌0.3%，卖空量成交2500股，较上一交易日减少89.13%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223163422a6c51e62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223163422a6c51e62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1515","BK1574","09939","BK1161"],"gpt_icon":0},{"id":"2592997683","title":"每日卖空追踪 | 同源康医药-B 12月18日卖空量成交2万股，卖空比例为1.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592997683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592997683?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:30","pubTimestamp":1766046628,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间12月18日，跌0.36%，卖空量成交2万股，较上一交易日减少20%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163422a6b1b434&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163422a6b1b434&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","09939","BK1161","BK1574","BK1515"],"gpt_icon":0},{"id":"2591607273","title":"每日卖空追踪 | 同源康医药-B 12月16日卖空量成交2.9万股，卖空比例为1.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591607273","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591607273?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:30","pubTimestamp":1765873828,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间12月16日，涨1.75%，卖空量成交2.9万股，较上一交易日减少51.26%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163431a6a8b683&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163431a6a8b683&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1515","BK1161","09939","BK1574"],"gpt_icon":0},{"id":"2591220607","title":"同源康医药-B12月16日主力净流入356.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2591220607","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591220607?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:15","pubTimestamp":1765872916,"startTime":"0","endTime":"0","summary":"12月16日, 同源康医药-B股价涨1.75%，报收13.39元，成交金额2817.8万元，换手率0.58%，振幅5.47%，量比0.71。同源康医药-B今日主力资金净流入356.0万元，上一交易日主力净流出8.3万元。该股近5个交易日上涨2.29%，主力资金累计净流入823.3万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2204.8万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216161610a6a8a0b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216161610a6a8a0b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1161","BK1574","09939","BK1515"],"gpt_icon":0},{"id":"2591636704","title":"同源康医药-B公布董事会成员名单及委员会任职情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2591636704","media":"金吾财讯","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591636704?lang=zh_cn&edition=full","pubTime":"2025-12-12 18:28","pubTimestamp":1765535306,"startTime":"0","endTime":"0","summary":"金吾财讯 | 同源康医药-B于2025年12月12日公布董事会成员名单及其在董事会各委员会的任职情况。公告显示，公司董事会由1名执行董事、5名非执行董事及4名独立非执行董事组成。吴玉生博士担任科学委员会主席及提名委员会成员，冷雨婷博士担任薪酬及考核委员会主席及审计委员会成员，蒋晓林先生担任提名委员会主席及薪酬及考核委员会成员。其他董事亦在各委员会中担任相应职务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512121852569539c62a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512121852569539c62a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1161","09939","BK1515","BK1574"],"gpt_icon":0},{"id":"2590557903","title":"同源康医药-B(02410)：江晓林获委任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2590557903","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590557903?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:32","pubTimestamp":1765528338,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)发布公告，江晓林先生(江先生)已获委任为独立非执行董事、董事会审计委员会(审计委员会)主席、董事会薪酬与考核委员会(薪酬委员会)成员及提名委员会(提名委员会)成员，自2025年12月12日起生效。江先生自2025年12月12日起获委任后，随即获委任为审计委员会主席以及薪酬委员会成员及提名委员会成员。本公司亦宣布，自2025年12月12日起，非执行董事顾虹博士获委任为审计委员会成员，非执行董事李钧博士不再担任审计委员会成员。为将更多时间投入其他业务和个人事务，李钧博士不再担任审计委员会成员。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380872.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","159938","BK1515","BK1574","02410","BK1161"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0435},{"period":"1month","weight":0.0427},{"period":"3month","weight":-0.1466},{"period":"6month","weight":-0.3098},{"period":"1year","weight":-0.6293},{"period":"ytd","weight":0.0435}],"compareEarnings":[{"period":"1week","weight":0.0202},{"period":"1month","weight":0.0281},{"period":"3month","weight":-0.0054},{"period":"6month","weight":0.0833},{"period":"1year","weight":0.3563},{"period":"ytd","weight":0.0202}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。该公司专注于小分子药物开发，其主要产品包括TY-9591、TY-302和TY-2136。TY-9591是一种第三代EGFR-TKI，对EGFR突变具有抗肿瘤作用。TY-302是一种为治疗乳腺癌及前列腺癌等晚期实体瘤而开发的强效、选择性口服CDK4/6抑制剂。TY-2136b为自主研发、口服ROS1/NTRK抑制剂，用于治疗实体瘤。","exchange":"SEHK","name":"同源康医药-B","nameEN":"TYK MEDICINES-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"同源康医药-B(02410)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供同源康医药-B(02410)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"同源康医药-B,02410,同源康医药-B股票,同源康医药-B股票老虎,同源康医药-B股票老虎国际,同源康医药-B行情,同源康医药-B股票行情,同源康医药-B股价,同源康医药-B股市,同源康医药-B股票价格,同源康医药-B股票交易,同源康医药-B股票购买,同源康医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"同源康医药-B(02410)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供同源康医药-B(02410)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}